ReviewESMO gastrointestinal oncology2026
Risk factors for second primary esophageal cancer after head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Review in ESMO gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with head and neck squamous cell carcinoma (HNSCC) are at an elevated risk of developing second primary tumors. Esophageal second primary tumors (ESPTs) represent a significant clinical challenge due to their frequent late detection and associated poor prognosis. This systematic literature review aims to identify and synthesize current evidence on risk factors for synchronous and metachronous ESPTs in patients with HNSCC. This can help identify individuals at highest risk so that targeted screening strategies can be created, which could ultimately improve long-term outcomes through earlier diagnosis. Materials and methods: A comprehensive search was conducted in PubMed, Web of Science, and Embase using a predefined search strategy. Eligible studies included observational, cohort, and case-control analyses involving adult patients with histologically confirmed HNSCC, either with or without an ESPT. Studies focusing exclusively on genome-associated risk factors, or those not addressing risk factors for ESPTs, were excluded. Meta-analyses were carried out when at least five studies reported on a specific risk factor. Results: Of 1338 records screened, 22 studies met the inclusion criteria and were included. In the meta-analyses, the following risk factors were found to be statistically significant for the development of ESPTs among HNSCC survivors: male sex [odds ratio (OR) 4.73; 95% confidence interval (CI) 2.15-10.40; Conclusions: Male sex, HNSCCs located in the hypopharynx or oropharynx, advanced tumor stage, and heavy alcohol consumption are associated with an increased risk of ESPT development. These findings may help identify susceptible patient subgroups who could benefit from future risk-adapted esophageal surveillance strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.